cambridge's bluebird bio licenses delivery tech to novartis, gsk
.
get connected
.
.
.
nbc encouraged him to take whatever time he needed, but olczyk promised his bosses he'd be back full-time by the
.
yet these drugs are not a "home run," says elizabeth loder, md, a professor of neurology at harvard medical school and chief of the division of headache at brigham & women's hospital.